OOIR: Observatory of International Research

Papers

(The TQCC of Paediatric Respiratory Reviews is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
A systematic cochrane review of corrector therapies (with or without potentiators) for people with cystic fibrosis with class II gene variants (most commonly F508DEL)	153
Regional oxygenation, perfusion and body and/or head position: Are preterm infants adversely impacted? A systematic review	33
Impact of prenatal and early life environmental exposures on normal human development	25
Does machine learning have a role in the prediction of asthma in children?	21
Socioeconomic determinants of outcomes in childhood asthma	21
Complicated intrathoracic tuberculosis: Role of therapeutic interventional bronchoscopy	20
The interplay between airway epithelium and the immune system – A primer for the respiratory clinician	20
Investigation of neutrophil/lymphocyte ratio and mean platelet volume in patients diagnosed with preterm labor	18
Post viral bronchiolitis obliterans in children: A rare and potentially devastating disease	17
Addition of long‐acting beta‐agonists to inhaled corticosteroids for asthma in preschool children: A systematic review	17
Comparison of video laryngoscopy and direct laryngoscopy for urgent intubation in newborn infants: A meta-analysis	17
Characterising the lifelong consequences of bronchopulmonary dysplasia	16
Learning from cystic fibrosis: How can we start to personalise treatment of Children’s Interstitial Lung Disease (chILD)?	16
Narrative review of clinical prediction models for paediatric community acquired pneumonia	16
The ethics of publishing in medical journals	14
Approaches to the management of haemoptysis in young people with cystic fibrosis	13
Cough medicines for children- time for a reality check	13
The management of upper airway obstruction in Pierre Robin Sequence	12
A Review Of Host-Specific Diagnostic And Surrogate Biomarkers In Children With Pulmonary Tuberculosis	11
Sudden Unexpected Death in Infancy [SUDI]: What the clinician, pathologist, coroner and researchers want to know	11
Issues affecting young people with asthma through the transition period to adult care	11
Exercise capacity and the psychosocial effect in preterm born infants – Should we do more?	9
Microbiology and management of respiratory infections in children with tracheostomy	9
Editorial Board	9
Covid-19 and the impact on young athletes	9

Unintended impacts of COVID-19 on the epidemiology and burden of paediatric respiratory infections	8
Post-tuberculosis lung disease in children and adolescents: A scoping review of definitions, measuring tools, and research gaps	8
Towards standardized and clinically relevant definitions of hypoxemia and hyperoxemia in preterm infants: A systematic review	7
Cystic Fibrosis screen positive, inconclusive diagnosis (CFSPID) to Cystic Fibrosis: Detecting disease with serial assessments	7
Respiratory infections in low and middle-income countries	7
A review of imaging in the diagnosis and management of complicated paediatric pneumonia	6
Health disparities in pediatric sleep-disordered breathing	6
Insulin-like growth factor-1 replacement therapy after extremely premature birth: An opportunity to optimize lifelong lung health by preserving the natural sequence of lung development	6
What we have learnt about trauma, loss and grief for children in response to COVID-19	6
Real-world respiratory and bulbar comorbidities of SMA type 1 children treated with nusinersen: 2-Year single centre Australian experience	6
Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology	6
Cystic Fibrosis-Related Diabetes: Clinical approach and knowledge gaps	6
Non-invasive respiratory support in preterm infants	5
Racial and skin color mediated disparities in pulse oximetry in infants and young children	5
Gaming the future	5
Necrotizing Pneumonia In Children: A Review	5
Weaving ethics into our activities	5
Variable and evolving degrees of CFTR dysfunction: Implications for diagnosis and clinical management	5
Face masks and protection against COVID-19 and other viral respiratory infections: Assessment of benefits and harms in children	5
Applying lessons learnt from research of child pneumonia management in Vietnam	5
Thoracic insufficiency syndrome: Approaches to assessment and management	4
Cheyne-stokes respiration in children with heart failure	4
A review of post COVID syndrome pathophysiology, clinical presentation and management in children and young people	4
Climate change and children’s respiratory health	4
Editorial Board	4
The potential effects of climate change on non-cystic fibrosis bronchiectasis in children	4
Race, bias, disparities, and pulmonary medicine	4
Pulmonary complications in children with Down syndrome: A scoping review	4
New modes of surfactant delivery	4
Exercise testing for young athletes	4
Impact of non-pharmacological initiatives for COVID-19 on hospital admissions due to pediatric acute respiratory illnesses	4
Diagnostic and interventional paediatric bronchoscopy in low and middle-income countries	4
Should an inhaled corticosteroid accompany each dose of fast-acting beta2-agonist for relief of asthma symptoms?	4
In modulators we trust	4
Physical activity and exercise training in cystic fibrosis	4